Journal article

Publication year: 2020

Pages: 550-558

Journal: Urologe A

Volume number: 59

Issue number: 5

ISSN: 0340-2592

eISSN: 1433-0563

DOI Link: https://doi.org/10.1007/s00120-020-01174-0

Publisher: Springer

Abstract: 
Background Urinary tract infections (UTIs) are among the most common infections. Especially complicated UTIs have a broad bacterial spectrum, sometimes having high antibiotic resistance rates. The clinical course might be very different and can range from spontaneous cure to fulminant sepsis. Objectives Which initial therapy is adequate for which UTI entity and what are the corresponding guidelines recommendations? Materials and methods This is a review of the current S3 guideline urinary tract infection, the guideline parenteral initial therapy of bacterial infections from the Paul Ehrlich Society, the guideline urological infections from the European Association of Urology (EAU) and the guideline on recurrent uncomplicated UTI in women from the American Urological Association (AUA). Results Adequate antibiotic therapy is based on the stratification into complicated and uncomplicated, as well as upper and lower infections, and on specific risk factors (e.g., urinary tract catheter) that can be classified according to the ORENUC criteria. Based on this classification, the choice for an empirical antibiotic therapy is made. The spectrum of pathogens should therefore be limited in order to use antibiotics with a narrow spectrum of activity and little collateral damage if possible, thus, preventing both the development of resistance and complications. Conclusions Adequate empirical antibiotic therapy and prophylaxis in line with guidelines is based on the clinical classification and risk factors.

Harvard Citation style: Ternes, B. and Wagenlehner, F. (2020) Guideline-based treatment of urinary tract infections, Urologe A, 59(5), pp. 550-558. https://doi.org/10.1007/s00120-020-01174-0

APA Citation style: Ternes, B., & Wagenlehner, F. (2020). Guideline-based treatment of urinary tract infections. Urologe A. 59(5), 550-558. https://doi.org/10.1007/s00120-020-01174-0